How do drugs relieve neurogenic pain?

Area of Science:

• Neurology
• Pharmacology

Background:

• Neurogenic pain affects approximately 1% of the population.
• The efficacy of current drug treatments for neuropathic pain is not well-established.
• Monotherapy with topical agents like capsaicin is often insufficient for managing neurogenic pain.

Purpose of the Study:

• To review the current landscape of drug treatments for neurogenic pain.
• To identify effective oral agents and emerging therapeutic targets for neuropathic pain.
• To explore future directions in pharmacotherapy for neurogenic pain.

Main Methods:

• Literature review of existing studies on neurogenic pain treatments.
• Analysis of the efficacy of various drug classes, including topical agents, oral medications, and local anesthetics.
• Examination of emerging therapeutic mechanisms and drug candidates.

Main Results:

• Tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and anticonvulsants are effective oral treatments for neurogenic pain.
• Intravenous local anesthetics show potential but require more controlled trial data.
• Multiple underlying mechanisms contribute to neurogenic pain, indicating potential for targeted therapies.

Conclusions:

• Current drug treatments for neurogenic pain have limitations, with oral agents showing more consistent efficacy than topical monotherapy.
• Future pharmacotherapy for neuropathic pain is expected to target specific mechanisms.
• Emerging treatments targeting N-methyl-D-aspartate (NMDA) receptors, adenosine receptors, and nitric oxide synthase show promise for neurogenic pain management.